Product information

Synagis 100 mg/ml
0.5 ml
palivizumab
3456753
0 / 10
Locked

Product properties

188039-54-5
J06BD01
AstraZeneca
Solution for injection
€476.88
EU/1/99/117/003
08054083013459
M1
Public
515244-01

Pharmacist Assessment

Chronically unavailable product

This product is officially available but is structurally not or barely supplied (current score 0/10, historical score 🔒/10). Consider using a structural alternative.

No available alternative found in the system. Consult the physician for a therapeutic alternative.
Note: commercialization of this product will be stopped on 30/11/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 30/11/2026

Commercial reasons

Adaptation of the treatment is possible
Available Active
Until 29/11/2026

Composition

1 ingredient

Substance Type Strength CAS
Active ingredient
100 mg/mL
188039-54-5

Additional information

Availability statistics

Available
0 days
3
0